-
公开(公告)号：CA2401557A1
公开(公告)日：2002-08-28
申请号：CA2401557
申请日：2001-02-28
Applicant: TORAY INDUSTRIES
Inventor： MUTOH MASATO , HOZUMI KAORI , SUDO TETSUO , UTSUMI JUN
Abstract: The invention is a medicine for improving retinal functions comprising a protein that improves ERG (electroretinogram) recordings. Particularly, a medicine containing tissue-factor-pathway inhibitor-2 or placental protein 5 as the active ingredient can be used for ophthalmic diseases such as glaucoma, occlusion disease of the retinal and choroidal vessels and retinal dysfunctions, as a medicine for improving retinal functions.
-
公开(公告)号：AU3598301A
公开(公告)日：2001-09-12
申请号：AU3598301
申请日：2001-02-28
Applicant: TORAY INDUSTRIES
Inventor： MUTOH MASATO , HOZUMI KAORI , SUDO TETSUO , UTSUMI JUN
Abstract: The invention is a medicine for improving retinal functions comprising a protein that improves ERG (electroretinogram) recordings. Particularly, a medicine containing tissue-factor-pathway inhibitor-2 or placental protein 5 as the active ingredient can be used for ophthalmic diseases such as glaucoma, occlusion disease of the retinal and choroidal vessels and retinal dysfunctions, as a medicine for improving retinal functions.
-
公开(公告)号：EP1260231A4
公开(公告)日：2004-06-09
申请号：EP01908117
申请日：2001-02-28
Applicant: TORAY INDUSTRIES
Inventor： MUTOH MASATO , HOZUMI KAORI , SUDO TETSUO , UTSUMI JUN
CPC classification number: A61K38/57
Abstract: Drugs for ameliorating retinal function which contain as the active ingredient sproteins having an effect of ameliorating electroretinogram (ERG). In particular, preparations containing as the active ingredient tissue-factor-pathway inhibitor-2 or placental protein 5 are usable as drugs for ameliorating retinal function in the treatment of ophthalmic diseases such as glaucoma, retinal vaso-occlusion and retinal malfunction.
-
-
Search Results
3
records
(took 0.021 seconds)
